Dipika Srivastav
About Dipika Srivastav
Data last updated:
Dipika Srivastav is a Director at German Homoeo Laboratories Private Limited (since 2017). The company operates in Pharma. German Homoeo Laboratories Private Limited reported revenue of ₹2.56 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 German Homoeo Laboratories Private Limited U24232UP1998PTC120090 | Director | 23 Jan 2017 | 1998 | ₹2.56 Cr (FY 2025) | Active |
Board colleagues of Dipika Srivastav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arti Pandey | 07711677 | German Homoeo Laboratories Private Limited | Director |
| Priti Srivastava | 00487717 | German Homoeo Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dipika Srivastav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dipika Srivastav
Dipika Srivastav currently holds 1 directorship: German Homoeo Laboratories Private Limited (Director, since 23 Jan 2017, revenue ₹2.56 Cr (FY 2025)).
Dipika Srivastav was first appointed on 23 Jan 2017 as Director at German Homoeo Laboratories Private Limited.
The current boards of Dipika Srivastav's companies include Arti Pandey (German Homoeo Laboratories Private Limited), Priti Srivastava (German Homoeo Laboratories Private Limited).